Issue 10/2017
Content (12 Articles)
Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use
- Leading Article
Sabrina Bagaglio, Caterina Uberti-Foppa, Giulia Morsica
Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects
- Leading Article
Mathurin Flamant, Josselin Rigaill, Stephane Paul, Xavier Roblin
Advanced Analgesic Drug Delivery and Nanobiotechnology
- Open Access
- Review Article
Nicoleta Stoicea, Juan Fiorda-Diaz, Nicholas Joseph, Muhammad Shabsigh, Carlos Arias-Morales, Alicia A. Gonzalez-Zacarias, Ana Mavarez-Martinez, Stephen Marjoribanks, Sergio D. Bergese
Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives
- Review Article
Matthew S. Farina, Kevin T. Lundgren, Joaquim Bellmunt
Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor
- Review Article
Joleen M. Hubbard, Axel Grothey
Ustekinumab: A Review in Moderate to Severe Crohn’s Disease
- Adis Drug Evaluation
Yvette N. Lamb, Sean T. Duggan
Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
- Letter to the Editor
David A. Schoenfeld
Authors’ Reply to Schoenfeld: “Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors”
- Letter to the Editor
Stefan Michiels, Everardo D. Saad, Marc Buyse
Erratum to: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
- Erratum
Bruno Geloneze, José Carlos de Lima-Júnior, Lício A. Velloso